Tim Ripperger

Dr. Tim Ripperger

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2017 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
TRTim Ripperger
Tim Ripperger
SBStefan S. Bielack
Stefan S. Bielack
ABArndt Borkhardt
Arndt Borkhardt
IBInes B. Brecht
Ines B. Brecht
BBBirgit Burkhardt
Birgit Burkhardt
CKChristian Kratz
Christian Kratz

20 April 2017 in Blood
Verified
Journal Article
Open access
PDF file
BTBianca Tesi
Bianca Tesi
JDJosef Davidsson
Josef Davidsson
MVMatthias Voss
Matthias Voss
ERElisa J Rahikkala
Elisa J Rahikkala
THTim D. Holmes
Tim D. Holmes
YBYenan T. Bryceson
Yenan T. Bryceson
Key Points: Autosomal-dominant SAMD9L gain-of-function mutations predispose to myeloid malignancies involving chromosome 7 aberrations. Hematopoietic reversions frequently occur postnatally and are associated with milder disease manifestations.

17 December 2008 in European Journal of Human Genetics
Verified
Journal Article
Closed access
TRTim Ripperger
Tim Ripperger
DGDorothea Gadzicki
Dorothea Gadzicki
AMAlfons Meindl
Alfons Meindl
BSBrigitte Schlegelberger
Brigitte Schlegelberger

1 March 2016 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
TRTim Ripperger
Tim Ripperger
BSBrigitte Schlegelberger
Brigitte Schlegelberger

23 November 2016 in Leukemia
Verified
Journal Article
Closed access
VPV Pastor
V Pastor
SHS Hirabayashi
S Hirabayashi
AKA Karow
A Karow
JWJ Wehrle
J Wehrle
EKE J Kozyra
E J Kozyra
MWM W Wlodarski
M W Wlodarski

29 August 2016 in Familial Cancer
Verified
Journal Article
Open access
PDF file
KWKatharina Wimmer
Katharina Wimmer
ABAndreas Beilken
Andreas Beilken
RNRainer Nustede
Rainer Nustede
TRTim Ripperger
Tim Ripperger
BLBritta Lamottke
Britta Lamottke
CKChristian P. Kratz
Christian P. Kratz
In a 14-year-old boy with polyposis and rectosigmoid carcinoma, we identified a novel POLE germline mutation, p.(Val411Leu), previously found as recurrent somatic mutation in ‘ultramutated’ sporadic cancers. This is the youngest reported cancer patient with polymerase proofreading-associated polyposis indicating that POLE mutation p.(Val411Leu) may confer a more severe phenotype than previously reported POLE and POLD1 germline mutations. The patient had multiple café-au-lait macules and a pilomatricoma mimicking the clinical phenotype of constitutional mismatch repair deficiency. We hypothesize that these skin features may be common to different types of constitutional DNA repair defects associated with polyposis and early-onset cancer.